Spain: two decades of leadership in innovative global health financing
Spain: two decades of leadership in innovative global health financing
25 March 2026
Spanish flag
For nearly 20 years, Spain has been a steadfast and increasingly ambitious partner in global immunisation, distinguished by its early and sustained embrace of innovative financing tools.
Announcements
As one of the founding donors to IFFIm in 2006, Spain helped pioneer a transformative development finance model – one that converts long-term government commitments into immediately available resources, enabling faster, more predictable delivery of life-saving vaccines to the world’s most vulnerable populations.
Spain’s initial pledge of €189.5 million marked a strong entry into innovative global health financing, reflecting both financial solidarity and strategic vision. Spain has since built on this foundation, renewing and expanding its engagement in 2022 with a long-term pledge of €100 million through 2035. Together, these commitments – totalling approximately €289.5 million (US$ 427 million) – underscore Spain’s evolution from an early supporter to a growing anchor donor in innovative vaccine financing.
At Gavi’s Replenishment Summit in June 2025 in Brussels, Spain further deepened this legacy by announcing a 30% increase in its contribution to Gavi. “Our commitment to the multilateral system and, in particular, to the global health system is absolute,” declared Pedro Sánchez during his speech. “Spain is willing to take a step forward, precisely now, when others hesitate, doubt, or retreat,” he continued.
Through its long-standing and growing commitments, Spain continues to play a catalytic role in delivering tangible, life-saving impact for children and communities worldwide.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.